Impairment of Circulating CD4+CD25+GARP+ Regulatory T Cells in Patients with Acute Coronary Syndrome

Background: Atherosclerosis (AS) is an inflammatory and immune disease. Regulatory T cells (Tregs) suppress the activation of T cells and have been shown to play a protective role during the pathogenesis of AS. However, specific markers for Tregs are lacking. Recently, glycoprotein A repetitions predominant (GARP) was discovered as a specific marker of activated Tregs, and we therefore utilized GARP as a specific surface marker for Tregs in the current study. Methods: To assess whether GARP+ Tregs are downregulated in patients with acute coronary syndrome (ACS), we examined CD4+CD25+GARP+ T cell frequencies as well as their associated cytokines and suppressive function. Additionally, we compared GARP expression to that of FOXP3, which may be more sensitive as a marker of activated Tregs in patients with ACS. Results: Patients with ACS demonstrated a significant decrease in circulating CD4+CD25+GARP+ Tregs. Moreover, the suppressive function of Tregs and levels of related cytokines were also impaired in ACS patients compared to those with stable angina (SA) or normal coronary artery (NCA). Additionally, after TCR stimulation, peripheral blood mononuclear cells (PBMCs) from patients with ACS exhibited a decrease in CD4+CD25+GARP+ Tregs. Conclusions: These fnding indicate that circulating CD4+CD25+GARP+ Tregs are impaired in patients withACS. Thus, targeting GARP may promote the protective function of Tregs in ACS.

• Publication year

  2014

• Venue

  Cellular Physiology and Biochemistry

• Publication date

  2014-02-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000358639PMID 24603196
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of the Expression of GARP/Latent TGF-β1 Complexes on Mouse T Cells and Their Role in Regulatory T Cell and Th17 Differentiation

  2013cited by this paper
• GARP–TGF-β Complexes Negatively Regulate Regulatory T Cell Development and Maintenance of Peripheral CD4+ T Cells In Vivo

  2013cited by this paper
• Soluble GARP has potent antiinflammatory and immunomodulatory impact on human CD4⁺ T cells.

  2013cited by this paper
• FOXP3 demethylation as a means of identifying quantitative defects in regulatory T cells in acute coronary syndrome.

  2013cited by this paper
• Inflammation in Atherosclerosis

  2012cited by this paper
• GARP regulates the bioavailability and activation of TGFβ

  2012cited by this paper
• Impaired Thymic Export and Increased Apoptosis Account for Regulatory T Cell Defects in Patients with Non-ST Segment Elevation Acute Coronary Syndrome*

  2012cited by this paper
• Cellular immunity, low-density lipoprotein and atherosclerosis: Break of tolerance in the artery wall

  2011cited by this paper
• Activation of Th17/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome.

  2011cited by this paper
• FOXP3 and GARP (LRRC32): the master and its minion

  2010cited by this paper
• FOXP3: required but not sufficient. the role of GARP (LRRC32) as a safeguard of the regulatory phenotype.

  2010cited by this paper
• The role of adaptive T cell immunity in atherosclerosis Ziad Mallat is a recipient of a Contrat d'Interface from Assistance Publique-Hôpitaux de Paris. Published, JLR Papers in Press, December 2, 2008.

  2009cited by this paper
• The Tregs' world according to GARP

  2009cited by this paper
• GARP (LRRC32) is essential for the surface expression of latent TGF-β on platelets and activated FOXP3+ regulatory T cells

  2009cited by this paper
• GARP: a key receptor controlling FOXP3 in human regulatory T cells

  2009cited by this paper
• Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells

  2009cited by this paper
• Oral Anti-CD3 Antibody Treatment Induces Regulatory T Cells and Inhibits the Development of Atherosclerosis in Mice

  2009cited by this paper
• Membrane protein GARP is a receptor for latent TGF‐β on the surface of activated human Treg

  2009cited by this paper
• Regulatory T cells: how do they suppress immune responses?

  2009cited by this paper
• Identification of a Regulatory T Cell Specific Cell Surface Molecule that Mediates Suppressive Signals and Induces Foxp3 Expression

  2008cited by this paper
• The Th17/Treg imbalance in patients with acute coronary syndrome.

  2008cited by this paper
• Role of Naturally Occurring CD4+CD25+ Regulatory T Cells in Experimental Atherosclerosis

  2007cited by this paper
• Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells

  2007cited by this paper
• Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production.

  2007cited by this paper
• The influence of the regulatory T lymphocytes on atherosclerosis.

  2007cited by this paper
• Induction of FOXP3 expression in naive human CD4+FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype.

  2007cited by this paper
• Altered status of CD4(+)CD25(+) regulatory T cells in patients with acute coronary syndromes.

  2006cited by this paper
• Patients With Acute Coronary Syndrome Show Oligoclonal T-Cell Recruitment Within Unstable Plaque: Evidence for a Local, Intracoronary Immunologic Mechanism

  2006cited by this paper
• Short-Term Treatment With Anti-CD3 Antibody Reduces the Development and Progression of Atherosclerosis in Mice

  2006cited by this paper
• Natural regulatory T cells control the development of atherosclerosis in mice

  2006cited by this paper
• Inflammation, atherosclerosis, and coronary artery disease.

  2005cited by this paper
• Inflammation, atherosclerosis, and coronary artery disease.

  2005cited by this paper
• Supporting Online Material

  2003cited by this paper
• Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis

  2002cited by this paper
• Atherosclerosis is an inflammatory disease

  1999cited by this paper

• Loss of effector Treg signature in APOB-reactive CD4+ T cells in patients with coronary artery disease

  2025cites this paper
• Coronary artery disease-associated immune gene RBP1 and its pan-cancer analysis

  2023cites this paper
• Downregulation of TIGIT Expression in FOXP3+Regulatory T Cells in Acute Coronary Syndrome

  2022cites this paper
• Construction of genetic classification model for coronary atherosclerosis heart disease using three machine learning methods

  2022cites this paper
• Antiretroviral therapy-treated HIV-infected adults with coronary artery disease are characterized by a distinctive regulatory T-cell signature

  2021cites this paper
• Modulation of Peripheral CD4+CD25+Foxp3+ Regulatory T Cells Ameliorates Surgical Stress-Induced Atherosclerotic Plaque Progression in ApoE-Deficient Mice

  2021cites this paper
• Elevated Methylation of FOXP3 (Forkhead Box P3)-TSDR (Regulatory T-Cell-Specific Demethylated Region) Is Associated With Increased Risk for Adverse Outcomes in Patients With Acute Coronary Syndrome.

  2019cites this paper
• Association between the level of CD4+ T lymphocyte microRNA-155 and coronary artery disease in patients with unstable angina pectoris

  2018cites this paper
• CD4+ CD25+ GARP+ regulatory T cells display a compromised suppressive function in patients with dilated cardiomyopathy

  2017cites this paper
• Progress and future opportunities in the development of vaccines against atherosclerosis

  2017cites this paper
• Intranasal immunization with heat shock protein 60 induces CD4+CD25+GARP+ and type 1 regulatory T cells and inhibits early atherosclerosis

  2016cites this paper
• Methylation of the FOXP3 upstream enhancer as a clinical indicator of defective regulatory T cells in patients with acute coronary syndrome.

  2016cites this paper
• Analysis of the Repertoire Features of TCR Beta Chain CDR3 in Human by High-Throughput Sequencing

  2016cites this paper
• Resting and Activated Natural Tregs Decrease in the Peripheral Blood of Patients with Atherosclerosis.

  2016cites this paper
• Crocetin Activates Foxp3 Through TIPE2 in Asthma-Associated Treg Cells

  2015cites this paper
• Heme Oxygenase-1 Restores Impaired GARP+CD4+CD25+ Regulatory T Cells from Patients with Acute Coronary Syndrome by Upregulating LAP and GARP Expression on Activated T Lymphocytes

  2015cites this paper
• Expansion of Myeloid-Derived Suppressor Cells in Patients with Acute Coronary Syndrome

  2015cites this paper
• Treating atherosclerosis with regulatory T cells.

  2015cites this paper